Found: 91
Select item for more details and to access through your institution.
Diagnostic performance of whole-body [<sup>18</sup>F]FDG PET/MR in cancer M staging: A systematic review and meta-analysis.
- Published in:
- European Radiology, 2024, v. 34, n. 1, p. 673, doi. 10.1007/s00330-023-10009-3
- By:
- Publication type:
- Article
Risk stratification for relapsed/refractory classical Hodgkin lymphoma integrating pretransplant Deauville score and residual metabolic tumor volume.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 5, p. 583, doi. 10.1002/ajh.26500
- By:
- Publication type:
- Article
Mesorectal nodal metastasis with seminal vesicle invasion in biochemically recurrent prostate cancer.
- Published in:
- BJU International, 2023, v. 132, n. 6, p. 664, doi. 10.1111/bju.16123
- By:
- Publication type:
- Article
Adenoid Cystic Carcinoma of the Breast: Mammographic, Sonographic, and Pathological Correlation.
- Published in:
- Breast Journal, 2002, v. 8, n. 1, p. 53, doi. 10.1046/j.1524-4741.2002.08012.x
- By:
- Publication type:
- Article
Mammographic Evolution of Fat Necrosis of the Breast.
- Published in:
- Breast Journal, 2001, v. 7, n. 5, p. 365, doi. 10.1046/j.1524-4741.2001.t01-1-20012.x
- By:
- Publication type:
- Article
Influence of molecular imaging on patient selection for treatment intensification prior to salvage radiation therapy for prostate cancer: a post hoc analysis of the PROPS trial.
- Published in:
- Cancer Imaging, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s40644-023-00570-x
- By:
- Publication type:
- Article
Fatal Interstitial Pneumonitis Related to Rituximab-Containing Regimen.
- Published in:
- Clinical Lymphoma & Myeloma, 2006, v. 6, n. 5, p. 407, doi. 10.3816/clm.2006.n.019
- By:
- Publication type:
- Article
Cystic lesions of the pancreatico-biliary tree: A schematic MRI approach.
- Published in:
- Indian Journal of Radiology & Imaging, 2017, v. 27, n. 2, p. 167, doi. 10.4103/ijri.IJRI_226_16
- By:
- Publication type:
- Article
SPECT/Multislice Low-Dose CT: A Clinically Relevant Constituent in the Imaging Algorithm of Nononcologic Patients Referred for Bone Scintigraphy.
- Published in:
- Journal of Nuclear Medicine, 2007, v. 48, n. 2, p. 319
- By:
- Publication type:
- Article
Improved Sentinel Node Identification by SPECT/CT in Overweight Patients with Breast Cancer.
- Published in:
- Journal of Nuclear Medicine, 2007, v. 48, n. 2, p. 201
- By:
- Publication type:
- Article
The Detection of Bone Metastases in Patients with High-Risk Prostate Cancer: <sup>99m</sup>Tc-MDP Planar Bone Scintigraphy, Single- and Multi-Field-of-View SPECT, <sup>18</sup>F-Fluoride PET, and <sup>18</sup>F-Fluoride PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 2, p. 287
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT in the Evaluation of Adrenal Masses.
- Published in:
- Journal of Nuclear Medicine, 2006, v. 47, n. 1, p. 32
- By:
- Publication type:
- Article
Solid Splenic Masses: Evaluation with <sup>18</sup>F-FDG PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2005, v. 46, n. 1, p. 52
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET in Evaluating Patients Treated for Metastatic Colorectal Cancer: Can We Predict Prognosis?
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 9, p. 1428
- By:
- Publication type:
- Article
Malignant Involvement of the Spine: Assessment by <sup>18</sup>F-FDG PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 2, p. 279
- By:
- Publication type:
- Article
Assessment of Malignant Skeletal Disease: Initial Experience with <sup>18</sup>F-Fluoride PET/CT and Comparison Between <sup>18</sup>F-Fluoride PET and <sup>18</sup>F-Fluoride PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 2, p. 272
- By:
- Publication type:
- Article
Normal and Abnormal <sup>18</sup>F-FDG Endometrial and Ovarian Uptake in Pre- and Postmenopausal Patients: Assessment by PET/CT.
- Published in:
- Journal of Nuclear Medicine, 2004, v. 45, n. 2, p. 266
- By:
- Publication type:
- Article
Comparison of 68 Ga-DOTATATE Positron Emmited Tomography/Computed Tomography and Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Detection of Liver Metastases from Well-Differentiated Neuroendocrine Tumors.
- Published in:
- Current Oncology, 2024, v. 31, n. 1, p. 521, doi. 10.3390/curroncol31010036
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL (PSMA) PET in the Management of Men with Biochemical Failure after Primary Therapy: Initial Clinical Experience of an Academic Cancer Center.
- Published in:
- Current Oncology, 2021, v. 28, n. 5, p. 3251, doi. 10.3390/curroncol28050282
- By:
- Publication type:
- Article
Neoadjuvant hyperfractionated chemoradiation and liver transplantation for unresectable perihilar cholangiocarcinoma in Canada.
- Published in:
- Journal of Surgical Oncology, 2018, v. 117, n. 2, p. 213, doi. 10.1002/jso.24833
- By:
- Publication type:
- Article
Ultra-low dose CT abdomen and pelvis for the detection of acute abdominal pathology in the emergency room: initial experience from an academic hospital.
- Published in:
- Emergency Radiology, 2021, v. 28, n. 1, p. 15, doi. 10.1007/s10140-020-01804-2
- By:
- Publication type:
- Article
Development of a radiomic signature for predicting response to neoadjuvant chemotherapy in muscle-invasive bladder cancer.
- Published in:
- Canadian Urological Association Journal, 2022, v. 16, n. 3, p. E113, doi. 10.5489/cuaj.7294
- By:
- Publication type:
- Article
Predictive radiomics signature for treatment response to nivolumab in patients with advanced renal cell carcinoma.
- Published in:
- Canadian Urological Association Journal, 2022, v. 16, n. 2, p. E94, doi. 10.5489/cuaj.7467
- By:
- Publication type:
- Article
Salvage lymph node dissection for prostate-specific membrane antigen (PSMA) positron emission tomography (PET)-identified oligometastatic disease.
- Published in:
- Canadian Urological Association Journal, 2021, v. 15, n. 10, p. 1, doi. 10.5489/cuaj.6988
- By:
- Publication type:
- Article
Predictive radiomics signature for treatment response to nivolumab in patients with advanced renal cell carcinoma.
- Published in:
- Canadian Urological Association Journal, 2021, v. 15, n. 9, p. 1, doi. 10.5489/cuaj.7467
- By:
- Publication type:
- Article
Case series--<sup>18</sup>F-DCFPyL-positron emission tomography/computed tomography (PET/CT) time of imaging.
- Published in:
- Canadian Urological Association Journal, 2021, v. 15, n. 7, p. E376, doi. 10.5489/cuaj.6984
- By:
- Publication type:
- Article
Canadian Urological Association best practice report: Prostatespecific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) and PET/magnetic resonance (MR) in prostate cancer.
- Published in:
- Canadian Urological Association Journal, 2021, v. 15, n. 6, p. 162, doi. 10.5489/cuaj.7268
- By:
- Publication type:
- Article
FDG-PET parameters predict for recurrence in anal cancer - results from a prospective, multicentre clinical trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
[ <sup>18</sup>F]FDG PET/CT in the Initial Staging and Restaging of Soft-Tissue or Bone Sarcoma in Patients with Negative or Equivocal Findings for Metastases or Limited Recurrence on Conventional Work-up: Results of a Prospective Multicenter Registry.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1371, doi. 10.2967/jnumed.122.265278
- By:
- Publication type:
- Article
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with <sup>177</sup>LuDOTATATE .
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.120.256727
- By:
- Publication type:
- Article
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with <sup>177</sup>LuDOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.120.256727
- By:
- Publication type:
- Article
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with <sup>177</sup>LuDOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.120.256727
- By:
- Publication type:
- Article
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with <sup>177</sup>Lu-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.120.256727
- By:
- Publication type:
- Article
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with <sup>177</sup>Lu-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.120.256727
- By:
- Publication type:
- Article
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with <sup>177</sup>Lu-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 6, p. 23, doi. 10.2967/jnumed.120.256727
- By:
- Publication type:
- Article
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with <sup>177</sup>Lu-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 5, p. 1, doi. 10.2967/jnumed.120.256727
- By:
- Publication type:
- Article
Quantitative <sup>68</sup>Ga-DOTATATE PET/CT parameters for the prediction of therapy response in patients with progressive metastatic neuroendocrine tumors treated with <sup>177</sup>Lu-DOTATATE.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 3, p. 1, doi. 10.2967/jnumed.120.256727
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.120.241737
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.120.241737
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.120.241737
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.120.241737
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.120.241737
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.120.241737
- By:
- Publication type:
- Article
18F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.120.241737
- By:
- Publication type:
- Article
<sup>18</sup>F-DCFPyL PET/CT in Patients with Subclinical Recurrence of Prostate Cancer: Effect of Lesion Size, Smooth Filter and Partial Volume Correction on Prostate Cancer Molecular Imaging Standardized Evaluation (PROMISE) criteria.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.120.241737
- By:
- Publication type:
- Article
The contribution of multiparametric pelvic & whole body MR to interpretation of <sup>18</sup>F-fluoromethylcholine or <sup>68</sup>Ga-HBED-CC PSMA-11 PET/CT in patients with biochemical failure following radical prostatectomy.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.118.225185
- By:
- Publication type:
- Article
The Contribution of Multiparametric Pelvic and Whole-Body MRI to Interpretation of <sup>18</sup>F-Fluoromethylcholine or <sup>68</sup>Ga-HBED-CC PSMA-11 PET/CT in Patients with Biochemical Failure After Radical Prostatectomy.
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 9, p. 1253, doi. 10.2967/jnumed.118.225185
- By:
- Publication type:
- Article
Prospective, Multisite, International Comparison of <sup>18</sup>F-Fluoromethylcholine PET/CT, Multiparametric MRI, and <sup>68</sup>Ga-HBED-CC PSMA-11 PET/CT in Men with High-Risk Features and Biochemical Failure After Radical Prostatectomy: Clinical Performance and Patient Outcomes
- Published in:
- Journal of Nuclear Medicine, 2019, v. 60, n. 6, p. 794, doi. 10.2967/jnumed.118.220103
- By:
- Publication type:
- Article
Measurement of Tumor Hypoxia in Patients with Advanced Pancreatic Cancer Based on <sup>18</sup>F-Fluoroazomyin Arabinoside Uptake.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 3, p. 361, doi. 10.2967/jnumed.115.167650
- By:
- Publication type:
- Article
Primary cystic peritoneal masses and mimickers: spectrum of diseases with pathologic correlation.
- Published in:
- Abdominal Imaging, 2015, v. 40, n. 4, p. 875, doi. 10.1007/s00261-014-0250-6
- By:
- Publication type:
- Article